Viewing Study NCT03325257


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-01-02 @ 9:15 AM
Study NCT ID: NCT03325257
Status: COMPLETED
Last Update Posted: 2021-09-14
First Post: 2017-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-ATU Study of Nivolumab
Sponsor: Nantes University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable melanoma View
None metastatic melanoma View
None Immunotherapy View
None Nivolumab View
None Temporary Auhorization for Use (ATU) View